In development: Guidance, quality standards and advice
Showing 1 to 3 of 3
| Title | Type | Expected publication date |
|---|---|---|
| Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768] | Technology appraisal guidance | TBC |
| Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke [TSID11920] | Technology appraisal guidance | TBC |
| Percutaneous insertion of a cerebral protection device during TAVI for preventing stroke | Interventional procedures guidance |